EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One ® Robotic HIFU in Radiorecurrent Prostate ...

EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue Seventh Consecutive Quarter of Year-Over-Year ...

EDAP TMS SA announced the successful treatment of the first patient in its phase I/II PULS Trial, which is investigating the use of High Intensity Focused Ultrasound (HIFU) technology for pancreatic ...

Non-inferior salvage treatment–free survival at 30 months favored HIFU (90%) versus salvage radical prostatectomy (86%), ...

Sonire Therapeutics announced today that it initiated its first U.S. clinical trial, SUNRISE-II, evaluating its pancreatic ...

Sonire Therapeutics, a U.S.-based clinical-stage medical device company, today announced the initiation of its first U.S. clinical trial, SUNRISE-II, evaluating its proprietary High-Intensity Focused ...

Focal therapy, including HIFU, targets only cancerous prostate areas, preserving organ function and minimizing side effects like erectile dysfunction and urinary incontinence. HIFU is suitable for ...

HIFU treatment failure is more likely when there is cancer involvement at the prostate base. PSMA PET/CT may improve lesion detection and patient selection for focal therapy. The locations of prostate ...

Investigators who conducted 2 clinical trials concluded that focal therapy is not inferior to radical prostatectomy with respect to treatment failure. Focal therapy such as high-intensity focused ...

MERIDIAN, Idaho — A new, less invasive prostate cancer treatment is now available through the Idaho Urologic Institute. It is called the High-Intensity Focused Ultrasound, or HIFU for short. It uses ...

It’s the second most common type of cancer among men and affects 1 in every 8 men in the United States. September is Prostate Cancer Awareness Month, and the American Cancer Society says this type of ...

In early 2024, the World Health Organization predicted that by 2050 there will be more than 35 million new cancer cases worldwide, an increase of 77% from 20 million in 2022. Driven by aging and ...